Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Abstract and The Classification of Human Metapneumovirus Abstract. ... Symptoms exhibited by patients are similar to those in respiratory syncytial virus-infected patients.

The votes in favor of Merck's shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom ...

Immunizations “are not all good or bad,” says the chair of the overhauled panel.

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a ...

The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...

A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...

A newly approved shot could soon help protect babies from respiratory syncytial virus, the top cause of hospitalization in US infants.

RSV is the focus of a new national pediatric guideline in China aimed at standardizing diagnosis, treatment, and prevention strategies for respiratory tract infections in children ...